Avanos Medical AVNS Net additions (releases) charged to costs and expenses
Net additions (releases) charged to costs and expenses at other companies
Other financials
Where this comes from
Reported directly by Avanos Medical in its filing.
Tagged under the XBRL concept us-gaap:ProvisionForDoubtfulAccounts.
The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Avanos Medical's net additions (releases) charged to costs and expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Avanos Medical's net additions (releases) charged to costs and expenses?
- Avanos Medical (AVNS) reported net additions (releases) charged to costs and expenses of -$400K in Q1 2026.
- How has Avanos Medical's net additions (releases) charged to costs and expenses changed year-over-year?
- Avanos Medical's net additions (releases) charged to costs and expenses decreased by 500.0% year-over-year, from $100K to -$400K.
- What is the long-term trend for Avanos Medical's net additions (releases) charged to costs and expenses?
- Over 3 years (2022 to 2025), Avanos Medical's net additions (releases) charged to costs and expenses has grown at a -32.5% compound annual growth rate (CAGR), from $2.6M to $800K.